ProCE Banner Activity

The Evolving Role of Immunotherapy in Advanced NSCLC

Slideset Download
Download this slideset from a live CCO symposium for an expert overview of the evolving immunotherapy landscape for advanced or metastatic NSCLC.

Released: June 07, 2022

Expiration: June 06, 2023

No longer available for credit.
Begin Activity

Share

Faculty

Julie Brahmer

Julie Brahmer, MD

Associate Professor of Oncology
Oncology/Upper Aerodigestive Cancer Program
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Lilly

Merck Sharp & Dohme Corp.

Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme

Faculty Disclosure

Primary Author

Julie Brahmer, MD

Associate Professor of Oncology
Oncology/Upper Aerodigestive Cancer Program
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland

Julie Brahmer, MD, MSc, FASCO, has disclosed that she has received consultant/advisor/speaker fees from Amgen, Blueprint, Bristol-Myers Squibb, Genentech/Roche, Lilly, Janssen, Johnson & Johnson, and Merck and funds for research support from Bristol-Myers Squibb.